Clinical Trial

Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the safety and efficacy of attapulgite in the treatment of obese individuals or overweight/obese individuals with type 2 diabetes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-02; most recent amendment 2025-08-30.
Status change: Not Yet Recruiting → Recruiting 2025-08-11
Trial Details
NCT Number NCT07103382
Lead Sponsor Second Xiangya Hospital of Central South University
Conditions Obesity
Enrollment 40 participants
Start Date 2025-06-26
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-05